Twist Bioscience Corp Quarterly Costs and Expenses in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Twist Bioscience Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2024.
  • Twist Bioscience Corp Costs and Expenses for the quarter ending September 30, 2024 was $121M, a 3.16% increase year-over-year.
  • Twist Bioscience Corp Costs and Expenses for the twelve months ending September 30, 2024 was $534M, a 15.5% increase year-over-year.
  • Twist Bioscience Corp annual Costs and Expenses for 2024 was $534M, a 15.5% increase from 2023.
  • Twist Bioscience Corp annual Costs and Expenses for 2023 was $462M, a 5.46% increase from 2022.
  • Twist Bioscience Corp annual Costs and Expenses for 2022 was $438M, a 53.8% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $534M $121M +$3.7M +3.16% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-18
Q2 2024 $530M $170M +$45.9M +36.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $484M $124M +$2.37M +1.95% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $482M $118M +$19.6M +19.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 $462M $117M +$2.88M +2.52% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-18
Q2 2023 $459M $125M +$7.25M +6.18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $452M $122M +$12.9M +11.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $439M $98.9M +$915K +0.93% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 $438M $114M +$36.4M +46.8% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-18
Q2 2022 $402M $117M +$40.1M +52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $362M $109M +$39.7M +57.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $322M $98M +$37M +60.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $285M $77.8M +$21.4M +37.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 $264M $77.1M +$27.7M +56.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $236M $69.2M +$17.8M +34.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $218M $61M -$12M -16.5% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $230M $56.4M +$9.09M +19.2% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 $221M $49.4M +$7.68M +18.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $213M $51.4M +$11.6M +29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $202M $73M +$38.6M +112% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $163M $47.3M Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $41.7M +$17.7M +73.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $39.8M +$17M +74.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $34.4M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q2 2018 $24M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $22.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.